Ryotaro Hashizume and colleagues use the CRISPR-Cas9 gene editing system to cleave the third chromosome in previously generated trisomy 21 cell lines derived from both pluripotent cells and skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback